Back to Search Start Over

Prospects for treatment of latent HIV.

Authors :
Barton KM
Burch BD
Soriano-Sarabia N
Margolis DM
Source :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2013 Jan; Vol. 93 (1), pp. 46-56. Date of Electronic Publication: 2012 Oct 10.
Publication Year :
2013

Abstract

Recent advances in antiretroviral therapy (ART) have drastically improved the quality of life for people with HIV infection. However, owing to the persistence of latent HIV in the presence of therapy, patients must remain on therapy indefinitely. Currently, the solution to the HIV pandemic rests on the prevention of new infections and many decades of ART for the steadily expanding number of people infected worldwide. ART is costly, requires ongoing medical care, and can have side effects, thereby preventing its universal availability. Therefore, to escape the ironic burdens of therapy, efforts have begun to develop treatments for latent HIV infection. Current approaches propose either complete eradication of infection or induction of a state of stringent control over viral replication without ART. This review will discuss these strategies in detail and their potential for clinical development.

Details

Language :
English
ISSN :
1532-6535
Volume :
93
Issue :
1
Database :
MEDLINE
Journal :
Clinical pharmacology and therapeutics
Publication Type :
Academic Journal
Accession number :
23212106
Full Text :
https://doi.org/10.1038/clpt.2012.202